Targeted Fgfr Inhibition Results In Hematologic And Cytogenetic Remission In A Myeloid Neoplasm Driven By A Novel Pcm1-Fgfr1 Fusion: Data From An Expanded Access Program

BLOOD(2019)

引用 0|浏览44
暂无评分
摘要
Introduction
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要